Michael Howell

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
La Jolla, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Howell
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael Howell

Form 4 holding Chief Scientific Officer and Head of Translational Science

Zura Bio Ltd

Security class
Class A ordinary shares
Shares / value
104,535
Estimated value
$632,437
Report date
18 May 2024
Price
$6.05
Ownership
Direct
Form 4 holding Chief Scientific Officer and Head of Translational Science

Zura Bio Ltd

Security class
Class A ordinary shares
Shares / value
114,395
Estimated value
$358,056
Report date
22 Apr 2024
Price
$3.13
Ownership
Direct
Form 4 holding Chief Scientific Officer and Head of Translational Science

Zura Bio Ltd

Security class
Class A ordinary shares
Shares / value
7,987
Estimated value
$48,321
Report date
18 May 2024
Price
$6.05
Ownership
By Corporation
Form 4 holding Chief Scientific Officer and Head of Translational Science

Zura Bio Ltd

Security class
Class A ordinary shares
Shares / value
7,987
Estimated value
$24,999
Report date
22 Apr 2024
Price
$3.13
Ownership
By corporation
Form 4 holding Chief Scientific Officer and Head of Translational Science

Zura Bio Ltd

Security class
Employee Share Option (Right to Buy)
Shares / value
295,000
Estimated value
Report date
18 Jun 2024
Price
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount

Insider Reports Filed by Michael Howell

4 ZURA

Zura Bio Ltd

Report period
18 Jun 2024
Transactions
1
Transaction value
$0
Accepted by SEC
21 Jun 2024, 18:11
Role
Chief Scientific Officer and Head of Translational Science
Next action
Open filing details
4 ZURA

Zura Bio Ltd

Report period
18 May 2024
Transactions
1
Transaction value
-$59,653
Accepted by SEC
08 Aug 2024, 16:15
Role
Chief Scientific Officer and Head of Translational Science
Next action
Open filing details
4 ZURA

Zura Bio Ltd

Report period
18 May 2023
Transactions
1
Transaction value
$0
Accepted by SEC
22 May 2023, 21:17
Role
Chief Scientific Officer & Head of Translational Science
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .